RWT Staff Repository Home

The repository contains the records of published and unpublished research authored by NHS staff working for the Royal Wolverhampton NHS Trust and its partners. The repository is managed by the Library and Knowledge Services of the Trust and supported by the Non-Medical Research Leads Network Group and the Research and Development Directorate.

If you are a member of RWT staff and you would like to submit an item to the repository, please fill in this online form.

If you have a list of publications you'd like to submit, please e-mail the repository rwh-tr.rwtrepository@nhs.net admin team.

For more information contact the library on 01902 695322 or email or take a look at our website. You will also find guidance on the webpage about publishing your work.

Select a community to browse its collections.

00- All RWT Publications by Year

This community lists all the RWT research outputs, collated by year of publication/issue.

01- Division 1 Surgical Division

This community includes all the groups within the surgical division as of April 2020. Including: Critical Care Services; Cardiology/Cardiothoracic Services; Surgical and Patient Services; Ophthalmology; Womens and Neonatal Group; Trauma and Orthopaedics Group; Head and Neck Group.

02- Division 2 Emergency and Medical Services Division

This community includes all the groups within the emergency and medical services division as of April 2020. Including: patient access group; rehabilitation and ambulatory group; medical group; emergency services group; oncology and haematology group.

03- Division 3 Community, Childrens and Support Services Division

This community includes all the groups within the community, childrens and support division as of April 2020. Including: childrens young people and sexual health; adult community and primary care services; diagnostics; pharmacy; therapies and ambulatory care group.

04- Division 4 Corporate Services

This community includes all the groups within the Division 4 as of May 2021. Including Service efficiency and delivery team; Emergency planning team; Corporate outpatients and Cancer tracking and improvement team.

05- Generic Cross Organisation Services

This community includes all those departments that provide generic clinical services across the trust, for example nursing and infection prevention.

06- Departments

This community includes all the non-clinical departments within the trust, for example education and training, library services, finance and governance.

07- Medical Physics and Clinical Engineering

This community includes radiation protection and safety, ultrasound, nuclear medicine, bone densitometry, radiotherapy, medical electronics, medical engineering, surgical instruments and computing.

08- Black Country Pathology Services

Set up in October 2018, the BCPS is a partnership of neighbouring trusts in providing pathology services across the Black Country. The four partners are: Sandwell and West Birmingham Hospitals NHS Trust; The Dudley Group NHS Foundation Trust; The Royal Wolverhampton NHS Trust and Walsall Healthcare NHS Trust.

09- NIHR Clinical Research Network West Midlands

The NIHR CRN West Midlands covers the areas of Shropshire, Staffordshire, County of the West Midlands, Warwickshire, Worcestershire and Herefordshire. The network is hosted by the Royal Wolverhampton NHS Trust.

10- Honorary Contracts

Much of the research which takes place at the RWT is a collaborative effort between staff and researchers who work for the our partners in Higher Education. These partners have their own research repositories.

11- COVID-19

Articles published by RWT staff are included within this collection.

12- Public Health

Included in this collection are general articles relating to public health.

Rare EGFR exon 20 S768I mutation predicts resistance to targeted therapy: a report of two cases

Pallan, Lalit; Koh, Pek; Taniere, Phillipe (Journal of Thoracic Oncology, Elsevier., 2014-10-01)

The importance of submitting data of clinical response to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) in patients with uncommon EGFR mutations has been encouraged.1 In view of this, we present ...
Is hormone replacement therapy in post-menopausal women associated with a reduced risk of oesophageal cancer?

Menon, Shyam (United European Gastroenterology Journal, Wiley Online, 2014-10-01)

Purpose The rise in oesophageal adenocarcinoma incidence in women with age is delayed compared with men until the post-menopausal period. A matched cohort study was therefore undertaken of post-menopausal women on hormone ...
Reduced testing frequency for glycated hemoglobin, HbA1c, is associated with deteriorating diabetes control.

Waldron, Jenna; Ford, Clare (Diabetes Care, American Diabetes Association., 2014-10-01)

OBJECTIVE We previously showed that in patients with diabetes mellitus, glycated hemoglobin (HbA1c) monitoring outside international guidance on testing frequency is widespread. Here we examined the relationship between ...
Natural cholesterol-lowering products: focus on probiotics.

Mistry, Punita (British Journal of Nursing, Mark Allen Publishing., 2014-10-01)

It is important to maintain healthy blood lipid profiles in order to reduce risk of cardiovascular disease. This article explores some of the evidence for natural cholesterol lowering products as a possible alternative to ...
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

Ferry, David (The Lancet, Elsevier., 2014-10-01)

Background VEGFR-2 has a role in gastric cancer pathogenesis and progression. We assessed whether ramucirumab, a monoclonal antibody VEGFR-2 antagonist, in combination with paclitaxel would increase overall survival in ...

Welcome to the RWT Staff Publications Repository

Communities in RWT Staff Repository

Recently Added

Rare EGFR exon 20 S768I mutation predicts resistance to targeted therapy: a report of two cases

Is hormone replacement therapy in post-menopausal women associated with a reduced risk of oesophageal cancer?

Reduced testing frequency for glycated hemoglobin, HbA1c, is associated with deteriorating diabetes control.

Natural cholesterol-lowering products: focus on probiotics.

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

Welcome to the RWT Staff Publications Repository

Communities in RWT Staff Repository

Recently Added

Rare EGFR exon 20 S768I mutation predicts resistance to targeted therapy: a report of two cases ﻿

Is hormone replacement therapy in post-menopausal women associated with a reduced risk of oesophageal cancer? ﻿

Reduced testing frequency for glycated hemoglobin, HbA1c, is associated with deteriorating diabetes control. ﻿

Natural cholesterol-lowering products: focus on probiotics. ﻿

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial ﻿

Rare EGFR exon 20 S768I mutation predicts resistance to targeted therapy: a report of two cases

Is hormone replacement therapy in post-menopausal women associated with a reduced risk of oesophageal cancer?

Reduced testing frequency for glycated hemoglobin, HbA1c, is associated with deteriorating diabetes control.

Natural cholesterol-lowering products: focus on probiotics.

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial